William Blair, Charles River and Market

Research analysts at William Blair decreased their FY2025 earnings per share (EPS) estimates for shares of AbbVie in a note ...
William Blair has recently reduced Applied Therapeutics Inc (APLT) stock to Mkt Perform rating, as announced on December 23, 2024, according to Finviz. Earlier, on December 2, 2024, UBS had reduced ...
Stephanie Braming, global head of investment management at William Blair, plans to retire in the fourth quarter, a news release said. She joined the Chicago-based firm in 2004 as a portfolio manager ...
Analysts at William Blair upped their FY2024 earnings per share (EPS) estimates for shares of Cheesecake Factory in a ...
The deal came nearly three years after CalPERS closed a $6 billion secondaries sale. Lexington Partners and CVC Secondary Partners acquired portions of that portfolio.
Vigil Neuroscience's VG-3927 Phase 1 trial shows strong safety, 50% sTREM2 reduction, and potential Alzheimer's treatment; Phase 2 begins Q3 2025.
Parsons Corp. (PSN) is sinking 9% today after investment bank William Blair cut its rating on the name to Market Perform from Outperform. Parsons sells tech products in the defense, intelligence, and ...
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...